BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28736583)

  • 1. MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers.
    Cheng WT; Rosario R; Muthukaruppan A; Wilson MK; Payne K; Fong PC; Shelling AN; Blenkiron C
    Clin Epigenetics; 2017; 9():72. PubMed ID: 28736583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of microRNA regulation on FOXL2 between adult-type and juvenile-type granulosa cell tumours in vitro.
    Rosario R; Blenkiron C; Shelling AN
    Gynecol Oncol; 2013 Apr; 129(1):209-15. PubMed ID: 23280087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult granulosa cell tumours (GCT): clinicopathological outcomes including FOXL2 mutational status and expression.
    Rosario R; Wilson M; Cheng WT; Payne K; Cohen PA; Fong P; Shelling AN
    Gynecol Oncol; 2013 Nov; 131(2):325-9. PubMed ID: 24007948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
    Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
    Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior.
    Costa MJ; Walls J; Ames P; Roth LM
    Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
    Lee H; Park CS; Deftereos G; Morihara J; Stern JE; Hawes SE; Swisher E; Kiviat NB; Feng Q
    World J Surg Oncol; 2012 Aug; 10():174. PubMed ID: 22925189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
    Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
    N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA analysis of gastric cancer patients from Saudi Arabian population.
    Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI
    BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
    Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
    BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
    Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
    Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of MicroRNA Expression Profiles in Patients with Giant Cell Tumor.
    Qin S; He NB; Yan HL; Dong Y
    Orthop Surg; 2016 May; 8(2):212-9. PubMed ID: 27384730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer.
    Lu Y; Govindan R; Wang L; Liu PY; Goodgame B; Wen W; Sezhiyan A; Pfeifer J; Li YF; Hua X; Wang Y; Yang P; You M
    Carcinogenesis; 2012 May; 33(5):1046-54. PubMed ID: 22331473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology of childhood germ cell tumours, focussing on the significance of microRNAs.
    Murray MJ; Nicholson JC; Coleman N
    Andrology; 2015 Jan; 3(1):129-39. PubMed ID: 25303610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2 and GATA4 are new prognostic factors for early-stage ovarian granulosa cell tumor-a long-term follow-up study.
    Färkkilä A; Andersson N; Bützow R; Leminen A; Heikinheimo M; Anttonen M; Unkila-Kallio L
    Cancer Med; 2014 Jun; 3(3):526-36. PubMed ID: 24687970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
    Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
    PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.
    Sim J; Kim Y; Kim H; Shin SJ; Kim DH; Paik SS; Jang K
    Medicine (Baltimore); 2018 Jun; 97(25):e10996. PubMed ID: 29923982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.